PFBT
ACOR

Parkside Financial Bank & Trust’s Acorda Therapeutics ACOR Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5
Closed – – 1688
2020
Q2 		$0 Buy
+5
New +$529 ﹤0.01% 1747
2019
Q4 		– Sell
-2
Closed -$1K – 1661
2019
Q3 		$1K Buy
2
+1
+100% +$544 ﹤0.01% 1504
2019
Q2 		$1K Buy
+1
New +$1.23K ﹤0.01% 1516
2019
Q1 		– Hold
0
– -$1K – 1678
2018
Q4 		– Hold
0
– – – 1375
2018
Q3 		– Hold
0
– – – 1439
2018
Q2 		– Hold
0
– – – 1433
2018
Q1 		– Hold
0
– – – 1349
2017
Q4 		– Hold
0
– – – 1270
2017
Q3 		– Hold
0
– – – 1278
2017
Q2 		– Hold
0
– – – 1305
2017
Q1 		– Hold
0
– – – 1256
2016
Q4 		– Hold
0
– – – 1258

Other funds holding ACOR

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parkside Financial Bank & Trust's ACOR Position: Q3 2020 in Review

Parkside Financial Bank & Trust sold out of Acorda Therapeutics (ACOR) in Q3 2020, closing a stake of 5 shares.

Parkside Financial Bank & Trust first reported a position in ACOR in Q2 2019 and held it in 3 quarters. The position peaked at $1K in Q3 2019. 60 funds tracked by Wall St. Rank hold ACOR as of Q3 2020.

  • Parkside Financial Bank & Trust reported no remaining Acorda Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 5 Acorda Therapeutics shares in Q3 2020.
  • Parkside Financial Bank & Trust first reported a position in Acorda Therapeutics in Q2 2019 and held it in 3 quarters.
  • Parkside Financial Bank & Trust's Acorda Therapeutics position peaked at $1K in Q3 2019.
  • 60 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2020.

Based on Parkside Financial Bank & Trust's 13F filing for Q3 2020, filed 6 Nov 2020.